{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:20:19Z","timestamp":1794345619031,"version":"4.9.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Foundation Science of China","award":["81802597"],"award-info":[{"award-number":["81802597"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13000-019-0864-7","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T01:03:01Z","timestamp":1566954181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["ALK rearrangement: a high-frequency alteration in ovarian metastasis from lung adenocarcinoma"],"prefix":"10.1186","volume":"14","author":[{"given":"Rui","family":"Bi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianming","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoxian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualei","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,28]]},"reference":[{"key":"864_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature05945","volume":"448","author":"M Soda","year":"2007","unstructured":"Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448:561\u20136.","journal-title":"Nature"},{"key":"864_CR2","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(16)00004-0","volume":"387","author":"F Barlesi","year":"2016","unstructured":"Barlesi F, Mazieres J, Merlio JP, et al. Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French cooperative thoracic intergroup (IFCT). Lancet. 2016;387:1415\u201326.","journal-title":"Lancet"},{"key":"864_CR3","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1158\/1078-0432.CCR-13-0318","volume":"19","author":"JF Gainor","year":"2013","unstructured":"Gainor JF, Varghese AM, Ou SH, et al. ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer. Clin Cancer Res. 2013;19:4273\u201381.","journal-title":"Clin Cancer Res"},{"key":"864_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/1476-4598-9-188","volume":"9","author":"X Zhang","year":"2010","unstructured":"Zhang X, Zhang S, Yang X, et al. Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression. Mol Cancer. 2010;9:188.","journal-title":"Mol Cancer"},{"key":"864_CR5","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1097\/JTO.0b013e31822eec5e","volume":"6","author":"S Popat","year":"2011","unstructured":"Popat S, Vieira de Araujo A, Min T, et al. Lung adenocarcinoma with concurrent exon 19 EGFR mutation and ALK rearrangement responding to erlotinib. J Thorac Oncol. 2011;6:1962\u20133.","journal-title":"J Thorac Oncol"},{"key":"864_CR6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/1759-7714.12146","volume":"6","author":"J Zhou","year":"2015","unstructured":"Zhou J, Zheng J, Zhao J, Sheng Y, Ding W. Poor response to gefitinib in lung adenocarcinoma with concomitant epidermal growth factor receptor mutation and anaplastic lymphoma kinase rearrangement. Thorac Cancer. 2015;6:216\u20139.","journal-title":"Thorac Cancer"},{"key":"864_CR7","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1002\/1097-0142(19840501)53:9<1978::AID-CNCR2820530929>3.0.CO;2-1","volume":"53","author":"MT Mazur","year":"1984","unstructured":"Mazur MT, Hsueh S, Gersell DJ. Metastases to the female genital tract. Analysis of 325 cases. Cancer. 1984;53:1978\u201384.","journal-title":"Cancer"},{"key":"864_CR8","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/01.pas.0000166363.76082.a0","volume":"29","author":"JA Irving","year":"2005","unstructured":"Irving JA, Young RH. Lung carcinoma metastatic to the ovary: a clinicopathologic study of 32 cases emphasizing their morphologic spectrum and problems in differential diagnosis. Am J Surg Pathol. 2005;29:997\u20131006.","journal-title":"Am J Surg Pathol"},{"key":"864_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12885-016-2169-5","volume":"16","author":"FY Niu","year":"2016","unstructured":"Niu FY, Zhou Q, Yang JJ, et al. Distribution and prognosis of uncommon metastases from non-small cell lung cancer. BMC Cancer. 2016;16:149.","journal-title":"BMC Cancer"},{"key":"864_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.4046\/trd.2014.77.6.258","volume":"77","author":"KA Lee","year":"2014","unstructured":"Lee KA, Lee JS, Min JK, et al. Bilateral ovarian metastases from ALK rearranged non-small cell lung Cancer. Tuberc Respir Dis (Seoul). 2014;77:258\u201361.","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"864_CR11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.lungcan.2013.11.022","volume":"83","author":"A Fujiwara","year":"2014","unstructured":"Fujiwara A, Higashiyama M, Kanou T, et al. Bilateral ovarian metastasis of non-small cell lung cancer with ALK rearrangement. Lung Cancer. 2014;83:302\u20134.","journal-title":"Lung Cancer"},{"key":"864_CR12","first-page":"151","volume":"1","author":"AH West","year":"2014","unstructured":"West AH, Yamada SD, MacMahon H, et al. Unique metastases of ALK mutated lung cancer activated to the adnexa of the uterus. Case Rep Clin Pathol. 2014;1:151\u20134.","journal-title":"Case Rep Clin Pathol"},{"key":"864_CR13","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.3892\/ol.2016.5292","volume":"12","author":"RT Mushi","year":"2016","unstructured":"Mushi RT, Yang Y, Cai Q, et al. Ovarian metastasis from non-small cell lung cancer with ALK and EGFR mutations: a report of two cases. Oncol Lett. 2016;12:4361\u20136.","journal-title":"Oncol Lett"},{"key":"864_CR14","doi-asserted-by":"publisher","first-page":"e4221","DOI":"10.1097\/MD.0000000000004221","volume":"95","author":"W Wang","year":"2016","unstructured":"Wang W, Wu W, Zhang Y. Response to crizotinib in a lung adenocarcinoma patient harboring EML4-ALK translocation with adnexal metastasis: a case report. Medicine (Baltimore). 2016;95:e4221.","journal-title":"Medicine (Baltimore)"},{"key":"864_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/15384047.2017.1310344","volume":"18","author":"X Jing","year":"2017","unstructured":"Jing X, Li F, Meng X, et al. Ovarian metastasis from lung adenocarcinoma with ALK-positive rearrangement detected by next generation sequencing: a case report and literatures review. Cancer Biol Ther. 2017;18:279\u201384.","journal-title":"Cancer Biol Ther"},{"key":"864_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/1066896917691613","volume":"25","author":"G Giordano","year":"2017","unstructured":"Giordano G, Cruz Viruel N, Silini EM, Nogales FF. Adenocarcinoma of the lung metastatic to the ovary with a signet ring cell component. Int J Surg Pathol. 2017;25:365\u20137.","journal-title":"Int J Surg Pathol"},{"key":"864_CR17","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.2169\/internalmedicine.0538-17","volume":"57","author":"H Sasano","year":"2018","unstructured":"Sasano H, Sekine A, Hirata T, et al. Ovarian metastases from ALK-rearranged lung adenocarcinoma: a case report and literature review. Intern Med. 2018;57:3271\u20135.","journal-title":"Intern Med"},{"key":"864_CR18","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/his.12722","volume":"67","author":"R Bi","year":"2015","unstructured":"Bi R, Bai QM, Yang F, et al. Microcystic stromal tumour of the ovary: frequent mutations of beta-catenin (CTNNB1) in six cases. Histopathology. 2015;67:872\u20139.","journal-title":"Histopathology"},{"key":"864_CR19","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1309\/AJCPHF51LSPCAXTA","volume":"141","author":"Z Li","year":"2014","unstructured":"Li Z, Dacic S, Pantanowitz L, et al. Correlation of cytomorphology and molecular findings in EGFR+, KRAS+, and ALK+ lung carcinomas. Am J Clin Pathol. 2014;141:420\u20138.","journal-title":"Am J Clin Pathol"},{"key":"864_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/his.13215","volume":"71","author":"HE Trejo Bittar","year":"2017","unstructured":"Trejo Bittar HE, Luvison A, Miller C, Dacic S. A comparison of ALK gene rearrangement and ALK protein expression in primary lung carcinoma and matched metastasis. Histopathology. 2017;71:269\u201377.","journal-title":"Histopathology"},{"key":"864_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3816\/CLC.2008.n.018","volume":"9","author":"VR Paralkar","year":"2008","unstructured":"Paralkar VR, Li T, Langer CJ. Population characteristics and prognostic factors in metastatic non-small-cell lung cancer: a fox Chase Cancer Center retrospective. Clin Lung Cancer. 2008;9:116\u201321.","journal-title":"Clin Lung Cancer"},{"key":"864_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/0003-4975(96)00220-2","volume":"62","author":"LE Quint","year":"1996","unstructured":"Quint LE, Tummala S, Brisson LJ, et al. Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg. 1996;62:246\u201350.","journal-title":"Ann Thorac Surg"},{"key":"864_CR23","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000352086","volume":"6","author":"S Diem","year":"2013","unstructured":"Diem S, Fruh M, Rodriguez R, Liechti P, Rothermundt C. EML4-ALK-positive pulmonary adenocarcinoma with an unusual metastatic pattern: a case report. Case Rep Oncol. 2013;6:316\u20139.","journal-title":"Case Rep Oncol"},{"key":"864_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.15746\/sms.15.033","volume":"21","author":"CKP Sooa Choi","year":"2015","unstructured":"Sooa Choi CKP, Kim SY, Yoon HK, Ro SM, Nam Y. Uterine cervix metastasis in lung adenocarcinoma with anaplastic lymphoma kinase rearrangement. Soonchunhyang Medical Science. 2015;21:142\u20135.","journal-title":"Soonchunhyang Medical Science"},{"key":"864_CR25","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1111\/1759-7714.12848","volume":"9","author":"X Chuang","year":"2018","unstructured":"Chuang X, Chen Y, Yu P, et al. ALK rearrangement in lung adenocarcinoma with concurrent cervix and breast metastases: a case report. Thorac Cancer. 2018;9:1513\u20138.","journal-title":"Thorac Cancer"},{"key":"864_CR26","unstructured":"Robert J. Kurman MLC, C. Simon Herrington, Robert H. Young. WHO Classification of tumors of female reproductive organs. International Agency for Research on Cancer, Lyon 2014; 4th edition, 27."},{"key":"864_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00000478-200303000-00001","volume":"27","author":"KR Lee","year":"2003","unstructured":"Lee KR, Young RH. The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases. Am J Surg Pathol. 2003;27:281\u201392.","journal-title":"Am J Surg Pathol"},{"key":"864_CR28","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1097\/00000478-200307000-00014","volume":"27","author":"JD Seidman","year":"2003","unstructured":"Seidman JD, Kurman RJ, Ronnett BM. Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol. 2003;27:985\u201393.","journal-title":"Am J Surg Pathol"},{"key":"864_CR29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3109\/10520295.2011.591838","volume":"87","author":"J Ye","year":"2012","unstructured":"Ye J, Hameed O, Findeis-Hosey JJ, et al. Diagnostic utility of PAX8, TTF-1 and napsin a for discriminating metastatic carcinoma from primary adenocarcinoma of the lung. Biotech Histochem. 2012;87:30\u20134.","journal-title":"Biotech Histochem"},{"key":"864_CR30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/PAI.0b013e318205b059","volume":"19","author":"J Ye","year":"2011","unstructured":"Ye J, Findeis-Hosey JJ, Yang Q, et al. Combination of napsin a and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung. Appl Immunohistochem Mol Morphol. 2011;19:313\u20137.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"864_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/COC.0000000000000508","volume":"42","author":"R Gupta","year":"2019","unstructured":"Gupta R, Amanam I, Rahmanuddin S, et al. Anaplastic lymphoma kinase (ALK)-positive tumors: clinical, radiographic and molecular profiles, and uncommon sites of metastases in patients with lung adenocarcinoma. Am J Clin Onco. 2019;42:337\u201344.","journal-title":"Am J Clin Onco"},{"key":"864_CR32","doi-asserted-by":"publisher","first-page":"4502","DOI":"10.1002\/cncr.27409","volume":"118","author":"RC Doebele","year":"2012","unstructured":"Doebele RC, Lu X, Sumey C, et al. Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer. Cancer. 2012;118:4502\u201311.","journal-title":"Cancer"},{"key":"864_CR33","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.21037\/jtd.2016.03.96","volume":"8","author":"L Hou","year":"2016","unstructured":"Hou L, Ren S, Su B, et al. High concordance of ALK rearrangement between primary tumor and paired metastatic lymph node in patients with lung adenocarcinoma. J Thorac Dis. 2016;8:1103\u201311.","journal-title":"J Thorac Dis"},{"key":"864_CR34","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1245\/s10434-009-0808-7","volume":"17","author":"T Takahashi","year":"2010","unstructured":"Takahashi T, Sonobe M, Kobayashi M, et al. Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene. Ann Surg Oncol. 2010;17:889\u201397.","journal-title":"Ann Surg Oncol"},{"key":"864_CR35","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/cncr.24181","volume":"115","author":"DW Wong","year":"2009","unstructured":"Wong DW, Leung EL, So KK, et al. The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS. Cancer. 2009;115:1723\u201333.","journal-title":"Cancer"},{"key":"864_CR36","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/his.12763","volume":"68","author":"T Kamata","year":"2016","unstructured":"Kamata T, Yoshida A, Shiraishi K, et al. Mucinous micropapillary pattern in lung adenocarcinomas: a unique histology with genetic correlates. Histopathology. 2016;68:356\u201366.","journal-title":"Histopathology"},{"key":"864_CR37","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/modpathol.2009.2","volume":"22","author":"K Inamura","year":"2009","unstructured":"Inamura K, Takeuchi K, Togashi Y, et al. EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset. Mod Pathol. 2009;22:508\u201315.","journal-title":"Mod Pathol"},{"key":"864_CR38","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/JTO.0b013e3182381515","volume":"7","author":"PL Sun","year":"2012","unstructured":"Sun PL, Seol H, Lee HJ, et al. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR\/TTF-1 expressions, and clinical features. J Thorac Oncol. 2012;7:323\u201330.","journal-title":"J Thorac Oncol"},{"key":"864_CR39","first-page":"8039","volume":"7","author":"Z Chen","year":"2014","unstructured":"Chen Z, Liu X, Zhao J, Yang H, Teng X. Correlation of EGFR mutation and histological subtype according to the IASLC\/ATS\/ERS classification of lung adenocarcinoma. Int J Clin Exp Pathol. 2014;7:8039\u201345.","journal-title":"Int J Clin Exp Pathol"},{"key":"864_CR40","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.cllc.2011.02.006","volume":"12","author":"HS Han","year":"2011","unstructured":"Han HS, Eom DW, Kim JH, et al. EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases. Clin Lung Cancer. 2011;12:380\u20136.","journal-title":"Clin Lung Cancer"},{"key":"864_CR41","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/annonc\/mdn679","volume":"20","author":"CH Gow","year":"2009","unstructured":"Gow CH, Chang YL, Hsu YC, et al. Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer. Ann Oncol. 2009;20:696\u2013702.","journal-title":"Ann Oncol"},{"key":"864_CR42","doi-asserted-by":"publisher","first-page":"794","DOI":"10.5858\/arpa.2012-0762-OA","volume":"138","author":"I Demidova","year":"2014","unstructured":"Demidova I, Barinov A, Savelov N, et al. Immunohistochemistry, fluorescence in situ hybridization, and reverse transcription-polymerase chain reaction for the detection of anaplastic lymphoma kinase gene rearrangements in patients with non-small cell lung cancer: potential advantages and methodologic pitfalls. Arch Pathol Lab Med. 2014;138:794\u2013802.","journal-title":"Arch Pathol Lab Med"},{"key":"864_CR43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/JTO.0b013e3182370e30","volume":"7","author":"SG Wu","year":"2012","unstructured":"Wu SG, Kuo YW, Chang YL, et al. EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with wild-type EGFR. J Thorac Oncol. 2012;7:98\u2013104.","journal-title":"J Thorac Oncol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-019-0864-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13000-019-0864-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-019-0864-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T16:43:44Z","timestamp":1664210624000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-019-0864-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,28]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["864"],"URL":"https:\/\/doi.org\/10.1186\/s13000-019-0864-7","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,28]]},"assertion":[{"value":"9 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study was approved by Fudan university cancer center ethics committee and consented to participate.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We confirm that the person\u2019s data in any form in this paper were approved by the person according to our consent form of Fudan university cancer center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}